Published On Jun 11, 2024
The fight over the blood oxygen feature has severely impacted Apple Watch sales. 📉 Apple Watch shipments dropped nearly 20% in Q1 2024 due to a patent dispute with Masimo Corporation. This segment explores the details of the legal battle, how it affects current Apple Watch models, and what it means for future releases.
Timestamps:
0:00 – Introduction to the blood oxygen feature controversy
0:02 – Blood oxygen feature status on Apple Watch Ultra
0:15 – Impact of the dispute on Apple Watch sales
0:27 – Overview of the patent dispute with Masimo Corporation
0:49 – Sales halt and software disablement details
1:11 – Timeline of Apple Watch sales disruptions
1:30 – Analyst insights on shipment declines
1:46 – Speculations on future Apple Watch models and features
2:04 – Comparison with other tech companies’ approaches
Stay updated on the latest Apple Watch news and subscribe to our channel for more in-depth tech discussions and analyses! 🚀🔔
More Apple news: http://www.cultofmac.com
Follow us!
Twitter: / cultofmac
Facebook: / cultofmac
Instagram: / cultofmac